Helsinki University Central Hospital — Helsinki

Public research footprint of Helsinki University Central Hospital, compiled from the ClinicalTrials.gov public registry.

344

Registered studies

Active

Recruiting now

208

Completed

Stopped or withdrawn

Most-studied conditions

Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome · Acute Ischemic Stroke (AIS) · Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis… · Chronic Total Occlusion of Coronary Artery

Recently updated registry entries

NCT03435796 — Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells (Recruiting)
NCT06616194 — A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent… (Active Not Recruiting)
NCT03075696 — A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Helsinki University Central Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.